These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 11684864)

  • 61. Weight-adjusted dosing of tinzaparin in pregnancy.
    Gibson PS; Newell K; Sam DX; Mansoor A; Jiang X; Tang S; Ross S
    Thromb Res; 2013 Feb; 131(2):e71-5. PubMed ID: 23245654
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effect of oral anticoagulation on clotting during hemodialysis.
    Ziai F; Benesch T; Kodras K; Neumann I; Dimopoulos-Xicki L; Haas M
    Kidney Int; 2005 Aug; 68(2):862-6. PubMed ID: 16014067
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Thrombophilia, thrombosis and pregnancy.
    Eldor A
    Thromb Haemost; 2001 Jul; 86(1):104-11. PubMed ID: 11486995
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Markers of coagulation activation for evaluation of the antithrombotic efficacy of heparin: a prospective study in acute deep venous thrombosis.
    Mesters RM; Mikoteit T; Schiller M; Krings W; Ostermann H; Kienast J
    Blood Coagul Fibrinolysis; 1995 Oct; 6(7):665-71. PubMed ID: 8562838
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Thrombin generation and low-molecular-weight heparin prophylaxis in pregnant women with thrombophilia.
    Selmeczi A; Roach RE; Móré C; Batta Z; Hársfalvi J; van der Bom JG; Boda Z; Oláh Z
    Thromb Haemost; 2015 Feb; 113(2):283-9. PubMed ID: 25392852
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prospective double-blind comparison between Fragmin and conventional low-dose heparin: thromboprophylactic effect and bleeding complications.
    Bergqvist D; Burmark US; Frisell J; Hallböök T; Lindblad B; Risberg B; Törngren S; Wallin G
    Haemostasis; 1986; 16 Suppl 2():11-8. PubMed ID: 3744131
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation.
    Barbour LA; Oja JL; Schultz LK
    Am J Obstet Gynecol; 2004 Sep; 191(3):1024-9. PubMed ID: 15467584
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The control of anti-coagulation in acute dialyses with sensitive laboratory parameters.
    Hafner G; Swars H; Ehrenthal W; Schinzel H; Weilemann LS; Prellwitz W
    Scand J Clin Lab Invest; 1992 Jun; 52(4):289-96. PubMed ID: 1332180
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Weight-adjusted LMWH prophylaxis provides more effective thrombin inhibition in morbidly obese pregnant women.
    Ismail SK; Norris L; O'Shea S; Higgins JR
    Thromb Res; 2014 Aug; 134(2):234-9. PubMed ID: 24984985
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Thrombin generation test as a marker for high risk venous thrombosis pregnancies.
    Joly BS; Sudrié-Arnaud B; Barbay V; Borg JY; Le Cam Duchez V
    J Thromb Thrombolysis; 2018 Jan; 45(1):114-121. PubMed ID: 29032523
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women.
    Folkeringa N; Brouwer JL; Korteweg FJ; Veeger NJ; Erwich JJ; Holm JP; van der Meer J
    Br J Haematol; 2007 Feb; 136(4):656-61. PubMed ID: 17223916
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of patient weight on the anticoagulant response to adjusted therapeutic dosage of low-molecular- weight heparin for the treatment of venous thromboembolism.
    Wilson SJ; Wilbur K; Burton E; Anderson DR
    Haemostasis; 2001; 31(1):42-8. PubMed ID: 11408748
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Laboratory control of minimal heparinization during haemodialysis in patients with a risk of haemorrhage.
    Hafner G; Klingel R; Wandel E; Ehrenthal W; Konheiser U; Lotz J; Köhler H; Prellwitz W
    Blood Coagul Fibrinolysis; 1994 Apr; 5(2):221-6. PubMed ID: 8054454
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
    Brenner B; Hoffman R; Blumenfeld Z; Weiner Z; Younis JS
    Thromb Haemost; 2000 May; 83(5):693-7. PubMed ID: 10823264
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children.
    Goldenberg NA; Knapp-Clevenger R; Manco-Johnson MJ;
    N Engl J Med; 2004 Sep; 351(11):1081-8. PubMed ID: 15356305
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial.
    Rodger MA; Hague WM; Kingdom J; Kahn SR; Karovitch A; Sermer M; Clement AM; Coat S; Chan WS; Said J; Rey E; Robinson S; Khurana R; Demers C; Kovacs MJ; Solymoss S; Hinshaw K; Dwyer J; Smith G; McDonald S; Newstead-Angel J; McLeod A; Khandelwal M; Silver RM; Le Gal G; Greer IA; Keely E; Rosene-Montella K; Walker M; Wells PS;
    Lancet; 2014 Nov; 384(9955):1673-83. PubMed ID: 25066248
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators.
    Harenberg J; Schmidt JA; Koppenhagen K; Tolle A; Huisman MV; Büller HR
    Thromb Haemost; 2000 May; 83(5):652-6. PubMed ID: 10823256
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Detection of decreased response to activated protein C during pregnancy by an endogenous thrombin potential-based assay.
    Sugimura M; Kobayashi T; Kanayama N; Terao T
    Semin Thromb Hemost; 1999; 25(5):497-502. PubMed ID: 10625209
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bleeding complications associated with low molecular weight heparin prophylaxis during pregnancy.
    Lindqvist PG; Dahlbäck B
    Thromb Haemost; 2000 Jul; 84(1):140-1. PubMed ID: 10928487
    [No Abstract]   [Full Text] [Related]  

  • 80. Changes in plasma coagulation markers with prophylactic treatment of low molecular weight heparin after cesarean section.
    Hirota Y; Sakai M; Nakabayashi M
    Semin Thromb Hemost; 2005 Jun; 31(3):253-60. PubMed ID: 16052393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.